[go: up one dir, main page]

WO2003011343A1 - Method of regenerating bone/chondral tissues by transferring transcriptional factor gene - Google Patents

Method of regenerating bone/chondral tissues by transferring transcriptional factor gene Download PDF

Info

Publication number
WO2003011343A1
WO2003011343A1 PCT/JP2002/006727 JP0206727W WO03011343A1 WO 2003011343 A1 WO2003011343 A1 WO 2003011343A1 JP 0206727 W JP0206727 W JP 0206727W WO 03011343 A1 WO03011343 A1 WO 03011343A1
Authority
WO
WIPO (PCT)
Prior art keywords
bone
chondral
tissues
transcriptional factor
transferring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/006727
Other languages
English (en)
French (fr)
Inventor
Toshimasa Uemura
Tetsuya Tateishi
Hiroko Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Japan Science and Technology Agency
National Institute of Advanced Industrial Science and Technology AIST
Japan Science and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, National Institute of Advanced Industrial Science and Technology AIST, Japan Science and Technology Corp filed Critical Japan Science and Technology Agency
Priority to EP02741405A priority Critical patent/EP1424082A4/en
Priority to JP2003516573A priority patent/JP4921692B2/ja
Priority to US10/484,699 priority patent/US20050063959A1/en
Publication of WO2003011343A1 publication Critical patent/WO2003011343A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP2002/006727 2001-07-27 2002-07-03 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene Ceased WO2003011343A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02741405A EP1424082A4 (en) 2001-07-27 2002-07-03 METHOD FOR THE REGENERATION OF BONE & CROP FABRIC BY CONVERSION OF THE TRANSCRIPTION FACTOR GENE
JP2003516573A JP4921692B2 (ja) 2001-07-27 2002-07-03 転写因子の遺伝子導入による骨・軟骨組織再生方法
US10/484,699 US20050063959A1 (en) 2001-07-27 2002-07-03 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001227979 2001-07-27
JP2001-227979 2001-07-27

Publications (1)

Publication Number Publication Date
WO2003011343A1 true WO2003011343A1 (en) 2003-02-13

Family

ID=19060554

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/006727 Ceased WO2003011343A1 (en) 2001-07-27 2002-07-03 Method of regenerating bone/chondral tissues by transferring transcriptional factor gene

Country Status (4)

Country Link
US (1) US20050063959A1 (ja)
EP (1) EP1424082A4 (ja)
JP (1) JP4921692B2 (ja)
WO (1) WO2003011343A1 (ja)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004074489A1 (ja) * 2003-02-18 2004-09-02 Japan Science And Technology Agency 脂肪細胞を利用した骨・軟骨組織の作製方法
WO2005035014A1 (ja) * 2003-10-15 2005-04-21 Japan Science And Technology Agency 転写因子を利用した骨・軟骨再生用インプラント
JP2005103272A (ja) * 2003-09-29 2005-04-21 Ethicon Inc 膝関節の前十字靭帯を置換する方法
WO2006090710A1 (ja) * 2005-02-25 2006-08-31 Japan Science And Technology Agency 骨組織の再生方法
JP2006521144A (ja) * 2003-03-27 2006-09-21 レジェンテック リミテッド 多孔質マトリックス
JP2006263459A (ja) * 2005-02-25 2006-10-05 Japan Science & Technology Agency 骨組織の再生方法
JP2007503849A (ja) * 2003-08-06 2007-03-01 アングストローム メディカ、インコーポレイテッド リン酸三カルシウム、その複合体、それらを組み入れたインプラント、及びそれらの製造方法
JP2012165719A (ja) * 2011-02-16 2012-09-06 National Institute Of Advanced Industrial Science & Technology 擬微小重力環境下での三次元癌組織モデルの構築方法
US9440005B2 (en) 2009-08-21 2016-09-13 National Institute Of Agrobiological Sciences Substrate for feeding cells and/or tissues, cell/tissue-feeder and method for the production of the same, method for the regeneration of tissues, and method for the production of porous bodies
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
US11147682B2 (en) 2017-09-08 2021-10-19 Pioneer Surgical Technology, Inc. Intervertebral implants, instruments, and methods

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150320833A1 (en) * 2012-12-13 2015-11-12 Steven L. Stice Ossification-inducing compositions and methods of use thereof
CN113116810B (zh) * 2021-03-29 2023-08-29 中国人民解放军空军军医大学 一种中药单体及高表达重组人骨形态发生蛋白细胞凝胶制剂及其制备方法和应用
CN113832109B (zh) * 2021-10-14 2023-11-21 中国人民解放军陆军军医大学第一附属医院 一种骨髓间充质干细胞外泌体及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030234A1 (en) * 1997-01-14 1998-07-16 Masahiro Iwamoto Compositions for osteogenesis and chondrogenesis
US6077987A (en) * 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432711B1 (en) * 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
DE19837438A1 (de) * 1998-08-18 2000-02-24 Biotechnolog Forschung Gmbh Rekombinante Humanzelle für Knochen- und Knorpelzellbildung
WO2001048148A1 (en) * 1999-12-28 2001-07-05 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
CN1498266A (zh) * 2001-01-30 2004-05-19 使用滑膜衍生的组织或细胞治疗及修复关节软骨缺损或损伤的组合物及方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030234A1 (en) * 1997-01-14 1998-07-16 Masahiro Iwamoto Compositions for osteogenesis and chondrogenesis
US6077987A (en) * 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ENOMOTO HIRAYUKI ET AL.: "Cbfa1 is a positive regulatory factor in chondrocyte maturation", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 12, 2000, pages 8695 - 8702, XP002957347 *
See also references of EP1424082A4 *
TAKAAKI YOSHIKAWA: "Baiyo hone ishoku ni yoru hone saisei-baiyo kotsuzui saibo ni yoru tissue engineering", PROTEIN, NUCLEIC ACID AND ENZYME, vol. 45, no. 13, 2000, pages 2289 - 2296, XP002957349 *
TOSHIFUMI KOMORI: "Hone keisei no master regulator Pebp2alphaA/Cbfa1", PROTEIN, NUCLEIC ACID AND ENZYME, vol. 45, no. 1, 2000, pages 13 - 17, XP002957348 *
UETA CHISATO ET AL.: "Skeletal malformations caused by overexpression of cbfa1 or its dominant nagative form in chondrocyte", JOURNAL OF CELL BIOLOGY, vol. 153, no. 1, April 2001 (2001-04-01), pages 87 - 99, XP002957346 *
WEI D. ET AL.: "Adenovirus-mediated expression of Cbfa1/Runx2 in C3H10T1/2 mesenchymal cells induces mineralization and expression of some, but not all osteoblast markers", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 16, no. SUPPL. 1, September 2001 (2001-09-01), pages S488, XP002957345 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004074489A1 (ja) * 2003-02-18 2004-09-02 Japan Science And Technology Agency 脂肪細胞を利用した骨・軟骨組織の作製方法
JP2006521144A (ja) * 2003-03-27 2006-09-21 レジェンテック リミテッド 多孔質マトリックス
JP4818905B2 (ja) * 2003-03-27 2011-11-16 レジェンテック リミテッド 多孔質マトリックス
US9486558B2 (en) 2003-03-27 2016-11-08 Locate Therapeutics Limited Porous matrix
US10011486B2 (en) 2003-08-06 2018-07-03 Pioneer Surgical Technology, Inc. Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
JP2007503849A (ja) * 2003-08-06 2007-03-01 アングストローム メディカ、インコーポレイテッド リン酸三カルシウム、その複合体、それらを組み入れたインプラント、及びそれらの製造方法
US8029755B2 (en) 2003-08-06 2011-10-04 Angstrom Medica Tricalcium phosphates, their composites, implants incorporating them, and method for their production
US8597604B2 (en) 2003-08-06 2013-12-03 Pioneer Surgical Technology, Inc. Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
US9517293B2 (en) 2003-08-06 2016-12-13 Pioneer Surgical Technology, Inc. Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
JP2005103272A (ja) * 2003-09-29 2005-04-21 Ethicon Inc 膝関節の前十字靭帯を置換する方法
US8016865B2 (en) 2003-09-29 2011-09-13 Depuy Mitek, Inc. Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
US9848978B2 (en) 2003-09-29 2017-12-26 Depuy Mitek, Llc Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
US8834538B2 (en) 2003-09-29 2014-09-16 Depuy Mitek, Llc Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
US9226816B2 (en) 2003-09-29 2016-01-05 Depuy Mitek, Llc Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
WO2005035014A1 (ja) * 2003-10-15 2005-04-21 Japan Science And Technology Agency 転写因子を利用した骨・軟骨再生用インプラント
JP2006263459A (ja) * 2005-02-25 2006-10-05 Japan Science & Technology Agency 骨組織の再生方法
WO2006090710A1 (ja) * 2005-02-25 2006-08-31 Japan Science And Technology Agency 骨組織の再生方法
US9440005B2 (en) 2009-08-21 2016-09-13 National Institute Of Agrobiological Sciences Substrate for feeding cells and/or tissues, cell/tissue-feeder and method for the production of the same, method for the regeneration of tissues, and method for the production of porous bodies
JP2012165719A (ja) * 2011-02-16 2012-09-06 National Institute Of Advanced Industrial Science & Technology 擬微小重力環境下での三次元癌組織モデルの構築方法
US11147682B2 (en) 2017-09-08 2021-10-19 Pioneer Surgical Technology, Inc. Intervertebral implants, instruments, and methods
US12279965B2 (en) 2017-09-08 2025-04-22 Xtant Medical Holdings, Inc. Intervertebral implants, instruments, and methods
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
USD968613S1 (en) 2017-10-09 2022-11-01 Pioneer Surgical Technology, Inc. Intervertebral implant

Also Published As

Publication number Publication date
EP1424082A1 (en) 2004-06-02
JPWO2003011343A1 (ja) 2004-11-18
EP1424082A4 (en) 2010-03-10
JP4921692B2 (ja) 2012-04-25
US20050063959A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
WO2003011343A1 (en) Method of regenerating bone/chondral tissues by transferring transcriptional factor gene
WO1999062424A3 (en) Bioengineered tubular graft prostheses
WO1999062425A3 (en) Bioengineered vascular graft prostheses
WO2006047310A3 (en) Hollow and porous orthopaedic or dental implant that delivers a biological agent
AU5173200A (en) Proximal femoral replacement implant and method of implanting the same
AU1515901A (en) Implant consisting of bone material
AU2003211066A1 (en) Artificial vessel scaffold and artificial organs therefrom
AU2777399A (en) Bone prosthesis and method of implantation
FR2801189B1 (fr) Implant pour raccourcissement osseux, et en particulier, metatarsien
AU6095700A (en) System for performing hip prosthesis surgery
WO2005086939A3 (en) Systems for bone replacement
AU5276600A (en) Kit for flushing medical devices and method of preparing the flushing solution
WO2005000159A3 (en) Tissue integration design for seamless implant fixation
AU2003299886A1 (en) Biologically implantable prosthesis and methods of using the same
AU2002365380A1 (en) Implant, method of making the same and use thereof for the treating of bones defects
EP1449500A3 (en) Modular bone implant, tool and method
HUP0103133A3 (en) Implant for repair of animal-cartilage, method for making the implant and cartilaginous tissue
ATE493492T1 (de) Verfahren und system zur herstellung von stammzellen aus fettgewebe
WO2004007682A3 (en) Methods and compositions for modulating t helper (th) cell development and function
AU2002326370A1 (en) Expandable polymer dental implant and method of use
WO2003018077A1 (en) Method of bone regeneration
AU3844599A (en) Biostable polyether polyurethane product
EP2213730A8 (en) Primary cultured adipocytes for gene therapy
NO20052949D0 (no) Implantat inneholdende dyrkede bruksceller og fremgangsmate for fremstilling
AU5026600A (en) Methods of regulating the condition of mammalian keratinous tissue

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003516573

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002741405

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002741405

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10484699

Country of ref document: US